Disease | precocious puberty |
Phenotype | C0242292|mccune-albright syndrome |
Sentences | 3 |
PubMedID- 22999294 | The objective of this study was to evaluate the safety and efficacy of fulvestrant (faslodextm), a pure estrogen receptor antagonist, in girls with progressive precocious puberty (pp) associated with mccune-albright syndrome (mas). |
PubMedID- 23087851 | Central precocious puberty may be associated with mccune-albright syndrome and neurofibromatosis type-1 (nf-1). |
PubMedID- 22051789 | Three atypical cases of suspected mccune-albright syndrome with gonadotropin-independent precocious puberty are presented. |
Page: 1